Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 0.31% | 195.65 | 1.3% | $518.42m | |
| GILD | Gilead Sciences, Inc. | -0.27% | 65.78 | 0.9% | $349.57m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.61% | 105.67 | 2.0% | $327.78m | |
| ILMN | Illumina, Inc. | 0.72% | 305.20 | 3.5% | $315.92m | |
| BIIB | Biogen Inc. | 0.19% | 235.62 | 1.3% | $306.06m | |
| CELG | Celgene Corporation | 0.28% | 98.95 | 1.3% | $294.56m | |
| A | Agilent Technologies, Inc. | 0.59% | 78.03 | 1.6% | $175.77m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 0.93% | 176.14 | 1.9% | $174.75m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.38% | 286.15 | 2.6% | $166.38m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.02% | 85.36 | 14.6% | $145.24m | |
| EXAS | Exact Sciences Corporation | -1.94% | 103.40 | 24.1% | $138.75m | |
| ACAD | ACADIA Pharmaceuticals Inc. | -1.14% | 41.68 | 13.9% | $125.44m | |
| INCY | Incyte Corporation | -0.54% | 78.12 | 2.5% | $85.20m | |
| ALDR | Alder Biopharmaceuticals, Inc. | -0.27% | 18.66 | 10.2% | $76.41m | |
| BMRN | BioMarin Pharmaceutical Inc. | 0.66% | 76.00 | 4.3% | $75.62m |
Company Profile
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY.